292 - The Etiology of Community-Acquired Pneumonia: How Appropriate are Current Guidelines?

10/5/2019

1:45 PM - 3:00 PM

Room: Walter E. Washington Convention Center, Ballroom ABC (3rd Floor)

MOC Credit: Maximum of 1.25 hours of MOC Credit
CME Credit: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
ACPE Credit: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: 0221-9999-19-413-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

discuss current knowledge on the etiology of CAP
list the strengths and pitfalls of current CAP treatment guidelines
explain the correlations between new diagnostic platforms and antibiotic use

Presentations:

1:45 PM - 2:10 PM
2835 - An Update on the Etiology of Community Acquired Pneumonia
Seema Jain, MD – California Department Of Public Health
2:10 PM - 2:35 PM
2836 - Strengths and Pitfalls of Treatment Guidelines in Community Acquired Pneumonia
Michael S. Niederman, MD – Division of Pulmonary and Critical Care, Weill Cornell Medicine
2:35 PM - 3:00 PM
2837 - New Diagnostic Platforms and Antibiotic Use in Community Acquired Pneumonia
Sara E. Cosgrove, MD, MS – Johns Hopkins

Moderator(s)

Daniel Musher, MD

Distiniguished Service Professor
Baylor College of Medicine
Houston, TX

Disclosure: Nothing to disclose
Kathryn Edwards, MD

Professor of Pediatrics
Vanderbilt University Medical Center
Nashville, Tennessee

Disclosure: Bionet: Consultant
GlaxoSmithKline: Advisory Board
IBM: Consultant
Roche: member of DSMB, Other Financial or Material Support
Sanofi Pasteur: member DSMB, Other Financial or Material Support
Sequiras: Member DSMB, Other Financial or Material Support
X4 Pharmaceuticals: Consultant

Speaker(s)

Sara Cosgrove, MD, MS

Professor of Medicine
Johns Hopkins
Baltimore, Maryland

Disclosure: Basilea: Consultant
Theravance: Consultant
Seema Jain, MD

Researcher
California Department Of Public Health
Berkeley, CA

Disclosure: Nothing to disclose
Michael Niederman, MD

Clinical Director and Associate Chief
Division of Pulmonary and Critical Care, Weill Cornell Medicine
Roslyn , NY

Disclosure: Astra Zeneca: Advisory Board
Merck: Advisory Board, Consultant
paratek: Advisory Board
Pfizer: Advisory Board, Consultant
polyphor: Advisory Board
Shionogi: Consultant, Grant/Research Support